[1] 朱宏, 施瑞华, 张国新, 凌亭生, 郝波. 环氧合酶-2、血管内皮生长因子和微血管密度与食管鳞癌病理特征的关系 [J]. 南京医科大学学报（自然科学版） 2005.doi:10.3969/j.issn.1007-4368.2005.02.004
[2] 汪洋, 林从尧, 周夏, WANG Yang, LIN Cong-yao, ZHOU Xia. 大肠癌中β-catenin表达及与COX-2、VEGF表达的关系 [J]. 肿瘤防治研究 2006.doi:10.3971/j.issn.1000-8578.2006.01.007
[3] 姬社青, 花亚伟, 马杰, 徐勇超, 韩少良. 结直肠癌COX-2、p53、PCNA和ki-67表达 [J]. 中国肿瘤 2004.doi:10.3969/j.issn.1004-0242.2004.08.020
[4] 陈赞雄, 吴振华, 许超贵, 林健. 大肠肿瘤COX-2的表达及与细胞增殖的关系 [J]. 肿瘤防治研究 2003.doi:10.3971/j.issn.1000-8578.2003.03.007
[5] 谷化平, 倪灿荣, 詹熔洲. CD15mRNA、CD44v6mRNA及nm23H1mRNA在乳腺癌组织中的表达及其临床意义 [J]. 中华医学杂志 2000.doi:10.3760/j:issn:0376-2491.2000.11.016
[6] CD44V6与肿瘤 [J]. 黑龙江医药科学 2005.
[7] 唐忠辉, 郭赛雄, 蔡庆发, 陈泰荔. MMP-9、TIMP-1在膀胱癌中的表达及其与浸润转移的关系研究 [J]. 国际泌尿系统杂志 2007.doi:10.3760/cma.j.issn.1673-4416.2007.02.002
[8] Uefunji K, chikura T, Mochizuki H. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer [J]. Clinical Cancer Research 2000, 6(01).
[9] Buecher B, Bouancheau D, Broquet A, Bezieau S, Denis MG, Bonnet C, Heymann MF, Jarry A, Galmiche JP, Blottiere HM. Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines. [J]. Anticancer Research: International Journal of Cancer Research and Treatment 2005, 1A(1A).
[10] Nozoe T, Ezaki T, Kabashima A. Significance of immunohistochemical expression of cyclooxygenase-2 in squamous cell carcinoma of the esophagus [J]. American Journal of Surgery 2005, 189(01).
[11] Garcia-Rodriguez LA, Huerta-Alvarez C. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. [J]. Epidemiology 2001, 1(1).
[12] Chen WS, Wei SJ, Liu JM. Tumor invasiveness and liver metastasis of colon cancer and inhibited by a COX-2-selective inhibitor, etodolac [J]. Cancer 2001, 91(06).
[13] Tsujii M, Kawano S, Tsuji S. Cyclooxygenase regulates angiogenesis induced by colon cancer cells [J]. Cell 1998, 93.
[14] Corvinus FM, Orth C, Moriggl R, Tsareva SA, Wagner S, Pfitzner EB, Baus D, Kaufmann R, Huber LA, Zatloukal K, Beug H, Ohlschlager P, Schutz A, Halbhuber KJ, Friedrich K. Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor Growth. [J]. Neoplasia: an international journal for oncology research 2005, 6(6).
[15] Liu XH, Kirschenbaum A, Yao S. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo [J]. Journal D Urologie 2006, 164.
[16] Beau S, Rigaud M, Beneyout JL. Resistance to apoptosis and cyclooxygenase-2 expression in a human adenocarci-noma cell line HT29CL.19A [J]. Anticancer Research 1998, 18(5A).
[17] O'Mahony CA, Beauchamp RD, Albo D, Tsujii M, Sheng HM, Shao J, Dubois RN, Berger DH. [J]. Surgery 1999.
[18] Bendardaf R, Elzagheid A, Lamlum H. E-cadherin, CD44s and CD44V6 correlate with tumourd ifferentiation in colorectal cancer [J]. Oncology Reports 2005, 13(05).
[19] Tsujii M, Kawano s, Dubois RN. Cyclooxygenase expression in human colon cancer cells increases metastatic potential [J]. Pruc Nail Acad Sci USA 1997, 94(07).
[20] Tomazawa S, Nagawa H, Tsuno N. Inhibition of hacmatogenous matastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522 [J]. Cancer 1999, 81(08). |
